Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cannabis Suisse (CSUI) EBIT (2016 - 2025)

Historic EBIT for Cannabis Suisse (CSUI) over the last 10 years, with Q4 2025 value amounting to -$74980.0.

  • Cannabis Suisse's EBIT rose 1877.28% to -$74980.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$280380.0, marking a year-over-year increase of 1035.47%. This contributed to the annual value of -$288013.0 for FY2025, which is 1209.48% down from last year.
  • Per Cannabis Suisse's latest filing, its EBIT stood at -$74980.0 for Q4 2025, which was up 1877.28% from -$84535.0 recorded in Q3 2025.
  • Cannabis Suisse's 5-year EBIT high stood at $58494.0 for Q1 2021, and its period low was -$674966.0 during Q2 2021.
  • Its 5-year average for EBIT is -$91038.7, with a median of -$62968.5 in 2023.
  • Examining YoY changes over the last 5 years, Cannabis Suisse's EBIT showed a top increase of 18971.2% in 2021 and a maximum decrease of 466670.9% in 2021.
  • Cannabis Suisse's EBIT (Quarter) stood at -$41351.0 in 2021, then increased by 28.96% to -$29375.0 in 2022, then crashed by 72.6% to -$50702.0 in 2023, then plummeted by 82.06% to -$92309.0 in 2024, then rose by 18.77% to -$74980.0 in 2025.
  • Its EBIT stands at -$74980.0 for Q4 2025, versus -$84535.0 for Q3 2025 and -$54077.0 for Q2 2025.